Depolarizing NMBAs
cause “excessive” depolarization of the neuromuscular junction
Nondepolarizing blockers (competitive blockers)
inhibit depolarization of the neuromuscular junction
Acetylcholine

Decamethonium Bromide
Note the structural similarities and dissimilarities to succinylcholine. Depolarizing. No longer used clinically.

Nondepolarizing (Competitive) - Benzylisoquinolinium Compounds

Non-depolarizing (Competitive) - Quarternary Steroidal Compound
Pancuronium

Non-depolarizing (Competitive) - Quarternary Steroidal Compounds
Vecuronium

Non-depolarizing (Competitive) - Benzylisoquinolinium Compounds
Atracurium besylate

More Atracurium Info - Refrigeration
Tracurium pH is adjusted to 3.25 to 3.65 with benzenesulfonic acid (besylate). Tracurium slowly loses potency with time and at the rate of approximately 6% per yr under refrigeration (5oC). Upon removal from refrigeration to room temperature, use within 14 days even if re-refrigerated. Tracurium is unstable in acids and bases, and is incompatible with alkaline solutions (eg, barbiturates).
Must be stored in an acid environment because in a basic environment you’re creating a larger population of hydroxyl ions and the hydroxyl can attack the ester and cleave it. So all esters are stored in acid.
Atracurium biotransformation – Hydrolysis
Nonspecific enzymatic ester hydrolysis; Rate of hydrolysis is independent of plasma cholinesterase concentration.
Hydrolysis rate is enhanced by physiologic decreases in acidity.

Atracurium biotransformation – More Hydrolysis: Metabolites
Metabolites are devoid of neuromuscular blocking activity and cardiovascular effect

Non-depolarizing (Competitive) NMBA – Benzylisoquinolinium Compounds:
Mivacurium Chloride

Cholinergics: Physostigmine
Inhibits AChE, therefore increase Ach at the cholinergic receptor and reverses the effects of non- depolarizing blockers

Cholinergics: Neostigmine

Cholinergics: Pyridostigmine Bromide

Cholinergics: Edrophonium chloride (Tensilon)

Suggamedex - reverses rocuronium
Sugammadex is a type of cyclodextrin that is capable of binding with Rocuronium and similar steroid neuromuscular blocking agents. Cyclodextrins are circular sugar-containing compounds that form a cone with a hollow core. The steroid compounds are “included” in the hollow cone of the cyclodextrin molecule and this causes reversal of their neuromuscular blocking effect.
